NRX Pharmaceuticals, Inc 10-K for FY2021
NRX Pharmaceuticals, Inc. (NRXP)
10-K
2022-03-31
For: 2021-12-31
View Original
Added on
April 11, 2026
About this 10-K
NRX Pharmaceuticals, Inc filed this 10-K on March 31, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $93.06M
- compared with a net loss of $51.78M a year earlier
- Diluted EPS
- -$1.98
- compared with -$1.51 a year earlier